首页> 外文期刊>ESC Heart Failure >Right ventricular involvement in cardiac sarcoidosis demonstrated with cardiac magnetic resonance
【24h】

Right ventricular involvement in cardiac sarcoidosis demonstrated with cardiac magnetic resonance

机译:心脏磁共振证实右室累及心脏结节病

获取原文
           

摘要

Abstract Aims Cardiac involvement in sarcoidosis is reported in up to 30% of patients. Left ventricular involvement demonstrated by contrast-enhanced cardiac magnetic resonance has been well validated. We sought to determine the prevalence and distribution of right ventricular late gadolinium enhancement in patients diagnosed with pulmonary sarcoidosis. Methods and results We prospectively evaluated 87 patients diagnosed with pulmonary sarcoidosis with contrast-enhanced cardiac magnetic resonance for right ventricular involvement. Pulmonary artery pressures were non-invasively evaluated with Doppler echocardiography. Patient characteristics were compared between the groups with and without right ventricular involvement, and right ventricular enhancement was correlated with pulmonary hypertension, ventricular mass, volume, and systolic function. Left ventricular late gadolinium enhancement was demonstrated in 30 patients (34%). Fourteen patients (16%) had right ventricular late gadolinium enhancement, with sole right ventricular enhancement in only two patients. The pattern of right ventricular enhancement consisted of right ventricular outflow tract enhancement in 1 patient, free wall enhancement in 8 patients, ventricular insertion point enhancement in 10 patients, and enhancement of the right side of the interventricular septum in 11 patients. Pulmonary arterial hypertension correlated with the presence of right ventricular enhancement ( P < 0.001). Right ventricular enhancement correlated with systolic ventricular dysfunction ( P < 0.001), hypertrophy ( P = 0.001), and dilation ( P < 0.001). Conclusions Right ventricular enhancement was present in 16% of patients diagnosed with pulmonary sarcoidosis and in 48% of patients with left ventricular enhancement. The presence of right ventricular enhancement correlated with pulmonary arterial hypertension, right ventricular systolic dysfunction, hypertrophy, and dilation.
机译:摘要目的据报道,结节病患者的心脏受累率高达30%。造影剂增强的心脏磁共振证实左心室受累已得到充分验证。我们试图确定诊断为肺结节病的患者右室晚期g增强的患病率和分布。方法和结果我们前瞻性评估了87例确诊为肺结节病伴对比增强心脏磁共振的右心室受累患者。多普勒超声心动图无创评估肺动脉压。比较了有无右室受累组的患者特征,并且右室增强与肺动脉高压,心室质量,容量和收缩功能相关。 30例患者(34%)证实左心室晚期增强。 14名患者(16%)右室晚期g增强,仅两名患者出现右室唯一增强。右心室增强的模式包括1例右室流出道增强,8例游离壁增强,10例心室插入点增强以及11例右室间隔的增强。肺动脉高压与右心室增强相关(P <0.001)。右心室增强与收缩期心室功能不全(P <0.001),肥大(P = 0.001)和扩张(P <0.001)相关。结论确诊为肺结节病的患者中有16%出现右心室增强,而左心室增强中有48%存在右心室增强。右心室增强与肺动脉高压,右心室收缩功能障碍,肥大和扩张有关。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号